Alison Ardrey

725 total citations
13 papers, 479 citations indexed

About

Alison Ardrey is a scholar working on Infectious Diseases, Small Animals and Pharmacology. According to data from OpenAlex, Alison Ardrey has authored 13 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 3 papers in Small Animals and 3 papers in Pharmacology. Recurrent topics in Alison Ardrey's work include Tuberculosis Research and Epidemiology (8 papers), Parasitic Diseases Research and Treatment (4 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). Alison Ardrey is often cited by papers focused on Tuberculosis Research and Epidemiology (8 papers), Parasitic Diseases Research and Treatment (4 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). Alison Ardrey collaborates with scholars based in United Kingdom, Spain and Peru. Alison Ardrey's co-authors include Stephen A. Ward, Benjamin Quartey, Nicholas Opoku, K. Awadzi, E. T. Addy, Simon K. Attah, G. Edwards, David Waterhouse, Geraint Davies and Mike Y. Osei‐Atweneboana and has published in prestigious journals such as Scientific Reports, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Alison Ardrey

13 papers receiving 467 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alison Ardrey United Kingdom	10	319	144	133	81	74	13	479
Michael Saeftel Germany	13	413 1.3×	437 3.0×	275 2.1×	44 0.5×	89 1.2×	16	843
Andrea Schiefer Germany	13	150 0.5×	72 0.5×	81 0.6×	10 0.1×	32 0.4×	25	423
D. F. McNeeley United States	9	620 1.9×	68 0.5×	61 0.5×	29 0.4×	401 5.4×	12	780
A P Dash India	13	234 0.7×	142 1.0×	68 0.5×	30 0.4×	47 0.6×	36	546
Christophe Hugnet France	10	60 0.2×	74 0.5×	45 0.3×	75 0.9×	165 2.2×	15	457
Foluke Fakorede Switzerland	6	67 0.2×	141 1.0×	75 0.6×	69 0.9×	54 0.7×	7	383
Jorge Oscar Errecalde Argentina	14	50 0.2×	50 0.3×	37 0.3×	155 1.9×	20 0.3×	49	431
Ana C. Mengarda Brazil	19	35 0.1×	419 2.9×	210 1.6×	239 3.0×	50 0.7×	30	701
Susan E. Marriner United Kingdom	17	77 0.2×	261 1.8×	246 1.8×	536 6.6×	15 0.2×	21	956
Gordana Panić Switzerland	17	65 0.2×	529 3.7×	225 1.7×	268 3.3×	58 0.8×	31	815

Countries citing papers authored by Alison Ardrey

Since Specialization

Citations

This map shows the geographic impact of Alison Ardrey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Ardrey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Ardrey more than expected).

Fields of papers citing papers by Alison Ardrey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Ardrey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Ardrey. The network helps show where Alison Ardrey may publish in the future.

Co-authorship network of co-authors of Alison Ardrey

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Ardrey. A scholar is included among the top collaborators of Alison Ardrey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Ardrey. Alison Ardrey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Pennington, Shaun H., Rose C. Lopeman, Alison Ardrey, et al.. (2022). Remdesivir–ivermectin combination displays synergistic interaction with improved in vitro activity against SARS-CoV-2. International Journal of Antimicrobial Agents. 59(3). 106542–106542. 8 indexed citations

Jin, Celina, Malick M. Gibani, Shaun H. Pennington, et al.. (2019). Treatment responses to Azithromycin and Ciprofloxacin in uncomplicated Salmonella Typhi infection: A comparison of Clinical and Microbiological Data from a Controlled Human Infection Model. PLoS neglected tropical diseases. 13(12). e0007955–e0007955. 23 indexed citations

Aljayyoussi, Ghaith, et al.. (2019). Intracellular Pharmacodynamic Modeling Is Predictive of the Clinical Activity of Fluoroquinolones against Tuberculosis. Antimicrobial Agents and Chemotherapy. 64(1). 2 indexed citations

Requena‐Méndez, Ana, Geraint Davies, David Waterhouse, et al.. (2018). Intra-individual effects of food upon the pharmacokinetics of rifampicin and isoniazid. Journal of Antimicrobial Chemotherapy. 74(2). 416–424. 4 indexed citations

Aljayyoussi, Ghaith, Victoria A. Jenkins, Raman Sharma, et al.. (2017). Pharmacokinetic-Pharmacodynamic modelling of intracellular Mycobacterium tuberculosis growth and kill rates is predictive of clinical treatment duration. Scientific Reports. 7(1). 502–502. 33 indexed citations

Waterhouse, David, Fraction K. Dzinjalamala, Alison Ardrey, et al.. (2015). Pharmacokinetics of anti-TB drugs in Malawian children: reconsidering the role of ethambutol. Journal of Antimicrobial Chemotherapy. 70(6). 1798–1803. 16 indexed citations

Requena‐Méndez, Ana, Geraint Davies, David Waterhouse, et al.. (2014). Effects of Dosage, Comorbidities, and Food on Isoniazid Pharmacokinetics in Peruvian Tuberculosis Patients. Antimicrobial Agents and Chemotherapy. 58(12). 7164–7170. 20 indexed citations

Srivastava, Abhishek, David Waterhouse, Alison Ardrey, & Stephen A. Ward. (2012). Quantification of rifampicin in human plasma and cerebrospinal fluid by a highly sensitive and rapid liquid chromatographic–tandem mass spectrometric method. Journal of Pharmaceutical and Biomedical Analysis. 70. 523–528. 43 indexed citations

Requena‐Méndez, Ana, Geraint Davies, Alison Ardrey, et al.. (2012). Pharmacokinetics of Rifampin in Peruvian Tuberculosis Patients with and without Comorbid Diabetes or HIV. Antimicrobial Agents and Chemotherapy. 56(5). 2357–2363. 41 indexed citations

10.

Hartkoorn, Ruben C., Shui‐Mei Khoo, D.J. Back, et al.. (2007). A rapid and sensitive HPLC–MS method for the detection of plasma and cellular rifampicin. Journal of Chromatography B. 857(1). 76–82. 36 indexed citations

11.

Awadzi, K., Daniel A. Boakye, G. Edwards, et al.. (2004). An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana. Annals of Tropical Medicine and Parasitology. 98(3). 231–249. 169 indexed citations

12.

Awadzi, K., G. Edwards, Nicholas Opoku, et al.. (2004). The safety, tolerability and pharmacokinetics of levamisole alone, levamisole plus ivermectin, and levamisole plus albendazole, and their efficacy against Onchocerca volvulus. Annals of Tropical Medicine and Parasitology. 98(6). 595–614. 30 indexed citations

13.

Awadzi, K., Geoffrey Edwards, B. O. L. Duke, et al.. (2003). The co-administration of ivermectin and albendazole - safety, pharmacokinetics and efficacy against Onchocerca volvulus. Annals of Tropical Medicine and Parasitology. 97(2). 165–178. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact